Tuberculous infection and biological response in man

Kekkaku

Volumn 79, Issue 9, 2004, Pages 541-545

  Shimokata, Kaoru ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Cytokine; Interferon ; Tuberculosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 18; MONOKINE; N(G) METHYLARGININE; PEROXYNITRITE;

ANTIGEN SPECIFICITY; BACTERIAL INFECTION; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONFERENCE PAPER; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; LYMPHOCYTE FUNCTION; MORBIDITY; PLEURA FLUID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION; TUBERCULOSIS; TUBERCULOUS PLEURISY;

HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; MACROPHAGES, ALVEOLAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITROUS ACID; T-LYMPHOCYTES; TUBERCULOSIS, PLEURAL;

EID: 7044222328     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Smith KA, Lachman LB, Oppenheim JJ, et al.: The functional relationship of the interleukins. J Exp Med. 1980; 151: 1551-1556.
2. Pettersson T, Klockars M, Hellstrom P-E, et al.: T and B lymphocytes in pleural effusions. Chest. 1978; 73: 49-51.
3. Pettersson T, Klockars M, Riska H: PHA and PPD reactivity of lymphocytes in pleural effusion. Chest. 1981; 80: 44-47.
4. Fujiwara H, Okuda Y, Fukukawa T, et al.: In vitro tuberculin reactivity of lymphocytes from patients with tuberculous pleurisy. Infect Immun, 1982; 35: 402-409.
5. Ellner JJ: Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med. 1978; 89: 932-933.
6. Ellner JJ: Suppressor adherent cells in human tuberculosis. J Immunol. 1978; 121: 2573-2579.
7. Ellner JJ, Daniel TM: Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol. 1979; 35: 250-257.
8. Ito Y, Nishiyama Y, Shimokata K, et al.: Immune interferon production in vitro as a quantitative indicator of cell-mediated immunity. Microbiol Immunol. 1979; 23: 1169-1177.
9. Shimokata K, Kawachi H, Kishimoto H, et al.: Local cellular immunity in tuberculous pleurisy. Am Rev Respir Dis. 1982; 126: 822-824.
10. Shimokata K, Kishimoto H, Takagi E, et al.: Determination of the T-cell subset producing γ -interferon in tuberculous pleural effusion. Microbiol Immunol. 1986; 30: 353-361.
11. Kurasawa T, Shimokata K: Cooperation between accessory cells and T lymphocytes in patients with tuberculous pleurisy. Chest. 1991; 100: 1046-1052.
12. Fujiwara H, Kleinhenz ME, Wallis RS, et al.: Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am. Rev Respir Dis. 1986; 133: 73-77.
13. Kurt-Jones EA, Beller DI, Mizel SB, et al.: Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci USA. 1985; 82: 1204-1208.
14. Fujiwara H, Tsuyuguchi I: Frequency of tuberculin-reactive T-lymphocytes in pleural fluid and blood from patients with tuberculous pleurisy. Chest. 1986; 89: 530-532.
15. Ribera E, Ocana I, Martinez-Vazquez JM, et al.: High level of interferon gamma in tuberculous pleural effusion. Chest. 1988;93:308-311.
16. Shimokata K, Saka H, Murate T, et al.: Cytokine content in pleural effusion. Comparison between tuberculous and carcinomatous pleurisy. Chest. 1991; 99: 1103-1107.
17. Zhang M, Gately MK, Wang E, et al.: Interleukin 12 at the site of disease in tuberculosis. J Clin Invest. 1994; 93: 1733-1739.
18. Okamura H, Tsutsui H, Kashiwamura S, et al.: Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv Immunol. 1998; 70: 281-312.
19. Dinarello CA: IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999; 103: 11-24.
20. Kawatsu H, Hasegawa Y, Takagi E, et al.: Human alveolar macrophages of anergic patients with lung cancer lack the responsiveness to recombinant interferon gamma. Chest. 1991; 100: 1277-1280.
21. Flesch IE, Kaufmann SH: Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect Immun. 1991; 59: 3213-3218.
22. Chan J, Xing Y, Magliozzo RS, et al.: Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med. 1992; 175: 1111-1122.
23. Jackett PS, Andrew PW, Aber VR, et al.: Guinea pig alveolar macrophages probably kill M. tuberculosis H37Rv and H37Ra in vivo by producing hydrogen peroxide. Adv Exp Med Biol. 1983; 162: 99-104.
24. Nibbering PH, Yoshida SI, van den Barselaar MT, et al.: Bacteriostatic activity of BCG/PPD-activated macrophages against Mycobacterium fortuitum does not involve reactive nitrogen or oxygen intermediates. Scand J Immunol. 1994; 40: 187-194.
25. Denis M.: Human monocytes/macrophages: NO or no NO? J Leukoc Biol. 1994; 55: 682-684.
26. Bermudez LE: Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide. Clin Exp Immunol. 1993; 91: 277-281.
27. Cameron ML, Granger DL, Weinberg JB, et al.: Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis. 1990; 142: 1313-1319.
28. Stamler JS, Singel DJ, Loscalzo J: Biochemistry of nitric oxide and its redox-activated forms. Science. 1992; 258: 1898-1902.
29. van der Vliet A, Eiserich JP, O'Neill CA, et al.: Tyrosine modification by reactive nitrogen species: a closer look. Arch Biochem Biophys. 1995; 319: 341-349.
30. Nozaki Y, Hasegawa Y, Ichiyama S, et al.: Nitric oxide dependent killing mechanism of Mycobacterium bovis BCG in human alveolar macrophages. Infect Immun. 1997; 65: 3644-3647.
31. Sauty A, Dziejman M, Taha RA, et al.: The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol. 1999; 162: 3549-3558.
32. Taub DD, Lloyd AR, Conlon K, et al.: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med. 1993; 177: 1809-1814.
33. Loetscher M, Gerber B, Loetscher P, et al.: Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med. 1996; 184: 963-969.
34. Liao F, Rabin RL, Yannelli JR, et al.: Human Mig chemokine: biochemical and functional characterization. J Exp Med. 1995; 182: 1301-1314.
35. Farber JM.: Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol. 1997; 61: 246-257.
36. Cole KE, Strick CA, Paradis TJ, et al.: Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med. 1998, 187: 2009-2021.
37. Bonecchi R, Bianchi G, Bordignon PP, et al.: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (This) and Th2s. J Exp Med. 1998; 187: 129-134.
38. Sallusto F, Lenig D, Mackay CR, et al.: Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J Exp Med. 1998; 187: 875-883.